Atara reports Q3 2026 results as tab-cel BLA resubmission moves toward March 2027 FDA decisionNov 10Quarterly updateAtara Biotherapeutics, Inc.
Atara reports FDA meeting progress on tabelecleucel BLA resubmission, trims costsAug 12Quarterly updateAtara Biotherapeutics, Inc.tabelecleucel